KRT17 and urinary bladder cancer: In our previous cross-sectional study11, EV mRNA marker screening was conducted using urine from the patients with bladder cancer, and three EV mRNA markers, SLC2A1, KRT17, and GPRC5A, were identified and validated in a small single-center study.